Clinical Trial Update: Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial [NA]

View source ↗

Summary

The BEAR trial is a Mayo Clinic-sponsored study of biologically adapted, dose-escalated radiotherapy for Ewing sarcoma and related round cell sarcomas, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Round Cell Sarcoma with Ewsr1-non-ets Fusion

Snippet

Sponsor: Mayo Clinic | Conditions: Ewing Sarcoma, Round Cell Sarcoma With EWSR1-non-ETS Fusion | NA | Status: RECRUITING